FDA Approves SEDASYS Propofol Sedation System

Ethicon Endo-Surgery has announced the approval by FDA for its SEDASYS device. This device is the first computer-assisted personalized sedation (CAPS) system which is a boon to clinicians in the endoscopy suites.

With this system, anesthesiologists and CRNAs can be replaced with computerized technology to administer propofol and to monitor minimal-to-moderate sedation in patients undergoing upper and lower endoscopies.

Digestive Tract Ulcers - Symptom Evaluation
A break in the mucus membrane lining of the digestive tract results in ulcers.

The company has also added that only ASA class I and II patients can be allowed to receive propofol via SEDASYS.

The company said that the state-of-the-art drug delivery and patient monitoring, the SEDASYS® System can help physician/nurse teams to ensure personalized sedation. Further, the device is capable of detecting and responding to signs of over-sedation by stopping or reducing delivery of propofol, increasing oxygen delivery and automatically instructing patients to take a deep breath.

The SEDASYS® System also keeps track of patients’ vital signs like blood pressure, heart rate, oxygen saturation and the degree of patient’s response.

Endoscopy Simulators for Training and Skill Assessment
The use of endoscopy simulators for training and assessing skills is addressed by the ASGE's new initiative.

Source-Medindia

European Society Will Soon Issue New Guidelines for Colon Capsule Endoscopy
The European Society of Gastrointestinal Endoscopy (ESGE) will soon issue a new set of guidelines on clinical utility and selection process of patients for colon capsule endoscopy (PillCam COLON 2).